Mr. Chair, I hear no answers on the Pfizer vaccine, no specific details on the Moderna vaccine and more reference to a vague portfolio. I am sure it is reassuring, as Canadians will see vaccines rolling out to billions of people around the planet, that we will have a robust portfolio in two years.
On May 12, the government signed an agreement between the National Research Council and CanSino that would “allow the NRC to advance a scale-up production process for a vaccine candidate.”
Did the government have the right to manufacture the CanSino vaccine in Canada?